Aurobindo Pharma declares Rs 7 interim dividend as Q2 net profit rises 32.5% to Rs 1,124 crore

The Aurobindo Pharma dividend record date is November 11, 2026, according to the company’s filing with NSE and BSE on November 4, 2026. The board declared an interim dividend of Rs 7 per equity share (700% of the Re 1 face value) for FY2026-27, payable on or before November 20, 2026.

Aurobindo Pharma dividend record date and payment

Shareholders whose names are on the company’s register on November 11 qualify for the Rs 7 payout. The record date is that cut-off. The board approved the dividend at its meeting on November 4, which began at 4:15 pm and ended at 6:00 pm.

The filing does not state an ex-dividend date. The exchanges set it, so check the NSE or BSE corporate actions page before trading around the date.

Q2 FY27 results announced with the dividend

The board also approved results for the quarter ended September 30, 2026. These are consolidated figures in Rs crore.

Measure (Rs crore)	Q2 FY27	Q2 FY26	Change
Revenue from operations	10,263	8,286	23.9%
Operating profit before forex and other income (EBITDA)	2,156	1,678	28.5%
Net profit	1,124	848	32.5%

The operating margin was 21.0%, against 20.3% a year earlier. Basic and diluted earnings per share were Rs 19.57.

What drove the growth

US revenue rose 25% to Rs 4,555 crore, which the company attributed to integration of acquired business, base business growth and new launches. Europe revenue rose 27% to Rs 3,161 crore. The company received final USFDA approval for 12 products in the quarter.

It reported a net cash position, including investments, of USD 189 million on September 30, 2026.

What to watch next

The payout is due by November 20. For other payouts and results, see our results news page.